19.07.2012 - Swiss drugmaker Novartis posted a smaller than expected fall in second-quarter core earnings and said tight cost control and strong sales of new drugs would help it cope with a...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)